With improvements in allied healthcare, the 134 million people worldwide diagnosed with glaucoma is likely to increase with better diagnostics, but also ensure earlier detection which can be treated sooner as evidenced by medtech company Nova Eye Medical (ASX: EYE) and rising sales of their advanced ophthalmic treatment technologies and devices. As the developers and
Read More
Worried parents across Europe and Asia Pacific will soon be able to know when their pre-verbal infants are feeling pain with medtech company PainChek (ASX: PCK) securing regulatory approval for their facial recognition app that assesses pain levels. Where infants cannot communicate their feelings, parents can take a quick smartphone video of the infant’s facial
Read More
Amid the growing concerns around coughing in public for the obvious reason, medtech company ResApp Health (ASX: RAP) has secured regulatory approval in Europe for their wearable device that analyses a person’s cough and the medical implications. The device, which is yet to be named, can be easily clipped on to a person’s shirt where
Read More
Health and safety products manufacturer VIP Gloves (ASX: VIP) is readying for a significant increase in their manufacturing capacity with approval now secured from European regulators for their nitrile gloves, bringing with it increased margins on products sold. The approval is widely recognised across the European Economic Area and signifies that VIP’s nitrile gloves conform
Read More
Australian medtech developer Proteomics International Laboratories (PILL, ASX: PIQ) has reached a landmark milestone having secured CE Mark certification for commericalisation of their in vitro diagnostic medical device in Europe, which can predict the early onset of diabetic kidney disease. The device, PromarkerD, takes a blood test which then creates a unique protein fingerprint which
Read More